880347-64-8

Basic information

• Product Name: D-Phenylalanine, 2,4-dichloro-, methyl ester, hydrochloride
• CAS NO: 880347-64-8
• Molecular Formula: C10H11Cl2NO2.ClH
• Molecular Weight: 284.57
• Mol File: 880347-64-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: D-Phenylalanine, 2,4-dichloro-, methyl ester, hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: D-Phenylalanine, 2,4-dichloro-, methyl ester, hydrochloride(880347-64-8)
• EPA Substance Registry System: D-Phenylalanine, 2,4-dichloro-, methyl ester, hydrochloride(880347-64-8)

Safety Data

• Hazardous Substances Data: 880347-64-8(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 114872-98-9 2,4-dichloro-D-phenylalanine 

Downstream Products

• 951774-73-5 C₁₁H₉Cl₂NO₃ 
• 1236065-54-5 C₁₆H₁₉Cl₂NO₄ 
• 1236065-52-3 C₁₄H₁₇Cl₂NO₄ 
• 1236065-50-1 C₁₃H₁₅Cl₂NO₄ 
• 879883-78-0 C₁₀H₁₁Cl₂NO₂ 

Relevant articles and documents

Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators

The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators, in particular as melanocortin 4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cache

Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators

The present invention relates to substituted aryl or heteroarylpiperidine derivatives of structure (I) as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.

SULFONAMIDE COMPOUNDS

Certain sulfonamide compounds are dual CCK1/CCK2 inhibitors useful in the treatment of CCK1/CCK2 mediated diseases.